Skip to main content

Table 1 Kaplan–Meier analysis of clinical GBM patients

From: Rho family GTPase 1 (RND1), a novel regulator of p53, enhances ferroptosis in glioblastoma

Clinicopathologic variables Number Average survival P value
All patients 45 16.005 ± 2.360  
Gender
 Male 24 13.786 ± 2.595 0.518
 Female 21 18.087 ± 3.903
Age at diagnosis
 < 55 24 19.163 ± 4.097 0.501
 ≥ 55 21 13.148 ± 1.726
KPS
 < 70 11 8.273 ± 2.149 0.018*
 ≥ 70 34 16.005 ± 2.360
Headache
 Yes 21 12.551 ± 1.532 0.775
 No 24 17.104 ± 3.520
Intracranial infection
 Yes 3 6 ± 4.041 0.05
 No 42 16.752 ± 2.489
Multiple lobe lesions
 Yes 11 15.697 ± 3.715 0.727
 No 34 15.913 ± 2.815
RND1 expression
 High 22 20.801 ± 3.912 0.007*
 Low 23 10.947 ± 1.828